Journal article
Preemptive Strategy for Ganciclovir Administration Against Cytomegalovirus in Liver Transplantation Recipients
Abstract
In utilizing a preemptive strategy to minimize the occurrence of symptomatic cytomegalovirus (CMV) infection following liver transplant, only patients with proven CMV activity by direct detection are treated. We applied the following preemptive strategy for CMV infection to 49 sequential liver transplant recipients between 1998 and 2001. Patients were monitored for CMV activity using CMV p65 antigen assay for the first 10 months of the study. …
Authors
Daly JS; Kopasz A; Anandakrishnan R; Robins T; Mehta S; Halvorsen M; Katz E
Journal
American Journal of Transplantation, Vol. 2, No. 10, pp. 955–958
Publisher
Elsevier
Publication Date
11 2002
DOI
10.1034/j.1600-6143.2002.21012.x
ISSN
1600-6135